DK2830653T3 - Mikropartikel-/nanopartikelvaccine mod malaria - Google Patents

Mikropartikel-/nanopartikelvaccine mod malaria Download PDF

Info

Publication number
DK2830653T3
DK2830653T3 DK13715076.9T DK13715076T DK2830653T3 DK 2830653 T3 DK2830653 T3 DK 2830653T3 DK 13715076 T DK13715076 T DK 13715076T DK 2830653 T3 DK2830653 T3 DK 2830653T3
Authority
DK
Denmark
Prior art keywords
microparticle
vaccine against
against malaria
nanoparticle vaccine
nanoparticle
Prior art date
Application number
DK13715076.9T
Other languages
Danish (da)
English (en)
Inventor
Thomas J Powell
Original Assignee
Artificial Cell Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artificial Cell Tech Inc filed Critical Artificial Cell Tech Inc
Application granted granted Critical
Publication of DK2830653T3 publication Critical patent/DK2830653T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK13715076.9T 2012-03-30 2013-03-20 Mikropartikel-/nanopartikelvaccine mod malaria DK2830653T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261617998P 2012-03-30 2012-03-30
PCT/US2013/033070 WO2013148426A1 (en) 2012-03-30 2013-03-20 Microparticle vaccine against malaria

Publications (1)

Publication Number Publication Date
DK2830653T3 true DK2830653T3 (da) 2021-09-13

Family

ID=48050943

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13715076.9T DK2830653T3 (da) 2012-03-30 2013-03-20 Mikropartikel-/nanopartikelvaccine mod malaria

Country Status (12)

Country Link
US (1) US9433671B2 (https=)
EP (1) EP2830653B1 (https=)
JP (1) JP6335876B2 (https=)
CN (1) CN104244971B (https=)
AU (1) AU2013240105B2 (https=)
BR (1) BR112014024374B1 (https=)
CA (1) CA2868450C (https=)
DK (1) DK2830653T3 (https=)
ES (1) ES2885806T3 (https=)
IL (1) IL234694B (https=)
MX (1) MX350709B (https=)
WO (1) WO2013148426A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012018628A1 (en) 2010-07-26 2012-02-09 Board Of Regents, The University Of Texas System Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US9974850B2 (en) 2013-01-25 2018-05-22 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
US9968665B2 (en) 2015-09-16 2018-05-15 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
WO2017075053A1 (en) * 2015-10-26 2017-05-04 Cour Pharmaceuticals Development Company Inc. Immune-modifying particles for the treatment of malaria
AU2019355843A1 (en) * 2018-10-04 2021-03-04 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
WO2024063789A1 (en) * 2022-09-23 2024-03-28 BioNTech SE Compositions for delivery of malaria antigens and related methods
JP2025533527A (ja) * 2022-09-23 2025-10-07 ビオンテック・ソシエタス・エウロパエア Plasmodium CSP抗原の送達のための組成物及び関連方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426077T3 (de) 1993-05-25 2004-09-02 Wyeth Holdings Corp. Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
EP1615665A4 (en) 2003-04-10 2010-10-06 3M Innovative Properties Co DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
US7348399B2 (en) 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
US20080233143A1 (en) 2005-02-07 2008-09-25 Lipotek Pty Ltd. Adjuvanting Material
DE102005044400A1 (de) 2005-09-16 2007-03-22 Capsulution Nanoscience Ag Verfahren zur Verkapselung und kontrollierten Freisetzung von schwer wasserlöslichen (hydrophoben) flüssigen und festen Wirkstoffen
CN101365724A (zh) 2005-10-25 2009-02-11 路易斯安那科技大学研究基金会 包含多肽的多层膜、涂层和微粒
EP1988896A4 (en) 2006-02-22 2011-07-27 3M Innovative Properties Co CONJUGATES TO MODIFY IMMUNE REACTIONS
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
US7723294B2 (en) 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
EP2002847A1 (en) 2007-06-12 2008-12-17 Capsulution Nanoscience AG Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device
WO2009082440A2 (en) 2007-12-18 2009-07-02 Vaxinnate Corporation Compositions of toll-like receptor agonists and malaria antigens and methods of use
US7846824B2 (en) 2008-03-18 2010-12-07 Applied Materials, Inc. Methods for forming a titanium nitride layer
JP2012523379A (ja) * 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン 免疫原性組成物およびその使用
CN106008716B (zh) 2010-07-07 2019-08-13 人工细胞科技公司 呼吸道合胞病毒抗原组合物和方法
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods

Also Published As

Publication number Publication date
CN104244971A (zh) 2014-12-24
IL234694B (en) 2021-09-30
US20130259945A1 (en) 2013-10-03
BR112014024374B1 (pt) 2022-10-18
MX350709B (es) 2017-09-14
CA2868450A1 (en) 2013-10-03
CN104244971B (zh) 2016-09-07
EP2830653A1 (en) 2015-02-04
HK1206972A1 (en) 2016-01-22
JP6335876B2 (ja) 2018-05-30
AU2013240105B2 (en) 2016-10-20
JP2015514087A (ja) 2015-05-18
CA2868450C (en) 2021-02-23
US9433671B2 (en) 2016-09-06
MX2014011713A (es) 2015-02-04
ES2885806T3 (es) 2021-12-15
EP2830653B1 (en) 2021-08-11
AU2013240105A1 (en) 2014-10-02
WO2013148426A1 (en) 2013-10-03
IL234694A0 (en) 2014-11-30
BR112014024374A2 (https=) 2017-06-20

Similar Documents

Publication Publication Date Title
BR112015014191A2 (pt) indanil carboxamidas difluorometilnicotínicas
EP2833926A4 (en) NEUROPHILIC NANOPARTICLES
HUE061273T2 (hu) Immunogén készítmény
ZA201508642B (en) Malaria vaccine
GB201318084D0 (en) Malaria vaccination
EP2937066A4 (en) FACE PLASTER
EP2876161A4 (en) VACCINE
DK2830653T3 (da) Mikropartikel-/nanopartikelvaccine mod malaria
EP2833521A4 (en) STATOR
PL2931304T3 (pl) Szczepionka wt1
BR112014005756A2 (pt) vacina
EP2884064A4 (en) MUFFLER
EP2832355A4 (en) CANCER AGENT
BR112014005362A2 (pt) vacinas de tumor com nanopartículas
EP2883547A4 (en) MEDICINE
DK2941519T3 (da) Sikkerhedshegn
EP2837387A4 (en) CANCER AGENT
FR2978048B1 (fr) Composition vaccinale contre le paludisme
EP2822599A4 (en) VACCINE FORMULATION
ZA201404512B (en) Malaria vaccine
HRP20190033T1 (hr) Pripravak
BR112014027644A2 (pt) 5-halogenopirazol-indanil-carboxamidas
FI20120230L (fi) Imukuppi
UA24920S (uk) Пакет
SM201200001S1 (it) Confezione